Cargando…

Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells

It is now admitted that in addition to acquired resistance, the tumor microenvironment contributes to the development of chemo-resistance and malignant progression. In a previous study, we showed that Dox induced apoptosis in FTC-133 cells by trigging JNK pathway. This process was accompanied by a d...

Descripción completa

Detalles Bibliográficos
Autores principales: Courageot, Marie-Pierre, Duca, Laurent, Martiny, Laurent, Devarenne-Charpentier, Emmanuelle, Morjani, Hamid, El Btaouri, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750475/
https://www.ncbi.nlm.nih.gov/pubmed/33365267
http://dx.doi.org/10.3389/fonc.2020.551228
_version_ 1783625494682402816
author Courageot, Marie-Pierre
Duca, Laurent
Martiny, Laurent
Devarenne-Charpentier, Emmanuelle
Morjani, Hamid
El Btaouri, Hassan
author_facet Courageot, Marie-Pierre
Duca, Laurent
Martiny, Laurent
Devarenne-Charpentier, Emmanuelle
Morjani, Hamid
El Btaouri, Hassan
author_sort Courageot, Marie-Pierre
collection PubMed
description It is now admitted that in addition to acquired resistance, the tumor microenvironment contributes to the development of chemo-resistance and malignant progression. In a previous study, we showed that Dox induced apoptosis in FTC-133 cells by trigging JNK pathway. This process was accompanied by a decrease of thrombospondin-1 (TSP-1) expression. Moreover, exogenous TSP-1 or its C-terminal-derived peptide interact with receptor CD47 and are able to protect FTC-133 cells against Dox-induced apoptosis. Here, we investigated the involvement of TSP-1/CD47 interaction in a context of acquired multidrug resistance in FTC-133 cells. To that end, we established a Dox-resistant cell line (FTC-133R cells) which developed a resistance against Dox-induced apoptosis. Cell viability was evaluated by Uptiblue assay, nuclear Dox was measured by microspectrofluorimetry, caspase activity was measured by fluorescence of cleaved caspase-3 substrate, gene expression was evaluated by RT-PCR and protein expression was examined by western-blot. Our results showed that FTC-133R overexpressed the P-gp and were 15-fold resistant to Dox. JNK phosphorylation and Dox-induced apoptosis were reduced in FTC-133R cells. Expression of CD47 was increased in FTC-133R cells but TSP-1 expression presented similar levels in two cell lines. VPL restored Dox nuclear uptake and FTC-133R cell sensitivity to apoptosis and induced a decrease in CD47 mRNA expression. Moreover, knockdown of CD47 in FTC-133R cells induced an increase in JNK activation and sensitized FTC-133R cells to Dox. Our data suggest that CD47 is able to contribute to the protection of FTC-133R cells against Dox-induced apoptosis and/or to potentiate the acquired Dox resistance.
format Online
Article
Text
id pubmed-7750475
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77504752020-12-22 Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells Courageot, Marie-Pierre Duca, Laurent Martiny, Laurent Devarenne-Charpentier, Emmanuelle Morjani, Hamid El Btaouri, Hassan Front Oncol Oncology It is now admitted that in addition to acquired resistance, the tumor microenvironment contributes to the development of chemo-resistance and malignant progression. In a previous study, we showed that Dox induced apoptosis in FTC-133 cells by trigging JNK pathway. This process was accompanied by a decrease of thrombospondin-1 (TSP-1) expression. Moreover, exogenous TSP-1 or its C-terminal-derived peptide interact with receptor CD47 and are able to protect FTC-133 cells against Dox-induced apoptosis. Here, we investigated the involvement of TSP-1/CD47 interaction in a context of acquired multidrug resistance in FTC-133 cells. To that end, we established a Dox-resistant cell line (FTC-133R cells) which developed a resistance against Dox-induced apoptosis. Cell viability was evaluated by Uptiblue assay, nuclear Dox was measured by microspectrofluorimetry, caspase activity was measured by fluorescence of cleaved caspase-3 substrate, gene expression was evaluated by RT-PCR and protein expression was examined by western-blot. Our results showed that FTC-133R overexpressed the P-gp and were 15-fold resistant to Dox. JNK phosphorylation and Dox-induced apoptosis were reduced in FTC-133R cells. Expression of CD47 was increased in FTC-133R cells but TSP-1 expression presented similar levels in two cell lines. VPL restored Dox nuclear uptake and FTC-133R cell sensitivity to apoptosis and induced a decrease in CD47 mRNA expression. Moreover, knockdown of CD47 in FTC-133R cells induced an increase in JNK activation and sensitized FTC-133R cells to Dox. Our data suggest that CD47 is able to contribute to the protection of FTC-133R cells against Dox-induced apoptosis and/or to potentiate the acquired Dox resistance. Frontiers Media S.A. 2020-12-07 /pmc/articles/PMC7750475/ /pubmed/33365267 http://dx.doi.org/10.3389/fonc.2020.551228 Text en Copyright © 2020 Courageot, Duca, Martiny, Devarenne-Charpentier, Morjani and El Btaouri http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Courageot, Marie-Pierre
Duca, Laurent
Martiny, Laurent
Devarenne-Charpentier, Emmanuelle
Morjani, Hamid
El Btaouri, Hassan
Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
title Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
title_full Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
title_fullStr Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
title_full_unstemmed Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
title_short Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
title_sort thrombospondin-1 receptor cd47 overexpression contributes to p-glycoprotein-mediated multidrug resistance against doxorubicin in thyroid carcinoma ftc-133 cells
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750475/
https://www.ncbi.nlm.nih.gov/pubmed/33365267
http://dx.doi.org/10.3389/fonc.2020.551228
work_keys_str_mv AT courageotmariepierre thrombospondin1receptorcd47overexpressioncontributestopglycoproteinmediatedmultidrugresistanceagainstdoxorubicininthyroidcarcinomaftc133cells
AT ducalaurent thrombospondin1receptorcd47overexpressioncontributestopglycoproteinmediatedmultidrugresistanceagainstdoxorubicininthyroidcarcinomaftc133cells
AT martinylaurent thrombospondin1receptorcd47overexpressioncontributestopglycoproteinmediatedmultidrugresistanceagainstdoxorubicininthyroidcarcinomaftc133cells
AT devarennecharpentieremmanuelle thrombospondin1receptorcd47overexpressioncontributestopglycoproteinmediatedmultidrugresistanceagainstdoxorubicininthyroidcarcinomaftc133cells
AT morjanihamid thrombospondin1receptorcd47overexpressioncontributestopglycoproteinmediatedmultidrugresistanceagainstdoxorubicininthyroidcarcinomaftc133cells
AT elbtaourihassan thrombospondin1receptorcd47overexpressioncontributestopglycoproteinmediatedmultidrugresistanceagainstdoxorubicininthyroidcarcinomaftc133cells